Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides

Acta Dermato-Venereologica

Volumn 92, Issue 3, 2012, Pages 264-268

  Kim, Sang Tae ^a   Kang, Dong Young ^a   Kang, Jin Seuk ^a   Baek, Jae Woo ^a   Jeon, Young Seung ^a   Suh, Kee Suck ^a  

^a Kosin University College of Medicine   (South Korea)

Author keywords

Methyl aminolaevulinic acid; Mycosis fungoides; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER;

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; FOLLOW UP; HUMAN; MALE; MYCOSIS FUNGOIDES; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RED LIGHT; REMISSION; TREATMENT RESPONSE;

ADULT; AGED; AMINOLEVULINIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; OCCLUSIVE DRESSINGS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REPUBLIC OF KOREA; SKIN NEOPLASMS;

EID: 84859744444     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1261     Document Type: Article

References (24)

1. Zackheim HS, Amin S, Kashani-Sabet M, McMillan A. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol 1999; 40: 418-425.
2. Oliver GF, Winkelmann RK. Unilesional mycosis fungoides: a distinct entity. J Am Acad Dermatol 1989; 20: 63-70.
3. Heald PW, Glusac EJ. Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant. J Am Acad Dermatol 2000; 42: 283-285.
4. Hodak E, Phenig E, Amichai B, Feinmesser M, Kuten A, Maron L, et al. Unilesional mycosis fungoides: a study of seven cases. Dermatology 2000; 201: 300-306.
5. Willemze R, Dreyling M. Primary cutaneous lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21: 177-180.
6. Zane C, Venturini M, Sala R, Calzavara-Pinton P. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed 2006; 22: 254-258.
7. Rud E, Gederaas O, Hogset A, Berg K. 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 2000; 71: 640-647.
8. Edström DW, Hedblad MA. Long-term follow-up of photodynamic therapy for mycosis fungoides. Acta Derm Venereol 2008; 88: 288-290.
9. Wolf P, Fink-Puches R, Cerroni L, Kerl H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol 1994; 31: 678-680.
10. Woringer F, Kolopp P. Lésion erythématosquameuse polycyclique de l'avant-bras évoluant depuis 6 ans chez un garcon de 13 ans: histologiquement infiltrat intra-épidermique d'apparence tumorale. Ann Dermatol Syphiligr 1940; 10: 945-958 cited from Dermatology 1999; 199: 174-176.
11. Recio ED, Zambrano B, Alonso ML, de Eusebio E, Martín M, Cuevas J, et al. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature. Int J Dermatol 2008; 47: 410-413.
12. Berger CL, Wang N, Christensen I, Longley J, Heald P, Edelson RL. The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens. J Invest Dermatol 1996; 107: 392-397.
13. Hoppe RT, Medeiros LJ, Warnke RA, Wood GS. CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 1995; 32: 448-453.
14. Dummer R, Kamarashev J, Kempf W, Häffner AC, Hess-Schmid M, Burg G. Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behaviour. Arch Dermatol 2002; 138: 199-203.
15. van Doorn R, Van Haselen CW, van Voorst Vader PC. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol 2000; 136: 504-510.
16. Orenstein A, Haik J, Tamir J, Winkler E, Trau H, Malik Z, et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. Dermatol Surg 2000; 26: 765-770.
17. Leman JA, Dick DC, Morton CA. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin Exp Dermatol 2002; 27: 516-518.
18. Coors EA, von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous Tcell lymphoma. J Am Acad Dermatol 2004; 50: 363-367.
19. Markham T, Sheahan K, Collins P. Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides. Br J Dermatol 2001; 144: 1262-1263.
20. Rhodes LE, de Rie M, Enstrom Y, Groves R, Morken T, Goulden V, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140: 17-23.
21. Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H. Preferential relative porphyrin enrichment in solar keratosis upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol 1998; 68: 218-221.
22. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003; 14: 99-106.
23. Plettenberg H, Stege H, Megahed M, Ruzicka T, Hosokawa Y, Tsuji T, et al. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999; 41: 47-50.
24. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743-751.